Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315492167> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2315492167 endingPage "A877" @default.
- W2315492167 startingPage "A877.1" @default.
- W2315492167 abstract "Objectives To evaluate the efficacy and safety of etanercept plus Tripterygium wilfordii polyglycoside(TWP) in elderly patients with active rheumatoid arthritis(RA). Methods 46 elderly patients with active RA were randomized to the treatment group ( n = 24) and the control group ( n = 22). The former was treated with ETN ( injected with 50mg/week subcutaneously, after 3 months,25mg/week) along with TWP(10mg, tid) ; the latter was treated with ETN and MTX (10mg/week). The whole course lasted 24 weeks, patients were assessed at weeks 0,2,6,14 and 24. The change from baseline in pain, tender joint count, swollen joint count, health assessment (HAQ), patient’s global assessment, physician’s global assessment, ESR and CRP were evaluated. The curative effect was statistically evaluated by the United States Institute of Rheumatology ACR 20, ACR50 and ACR70 improvement criteria. Meanwhile adverse events were recorded and evaluated. Results At week 2, the ACR20 was achieved in 58% of patients receiving ETN plus TWP, compared with 56% of patients receiving ETN plus MTX(p>0.05). The results for other clinical signs and symptoms and quality of life showed no difference between these two groups(P>0.05). At week 24, the ACR20 improvement was achieved in 80.2% of patients receiving ETN plus TWP, compared with 78% of patients receiving ETN plus MTX(p>0.05). There was no significant difference between the two groups in adverse effects. Conclusions These two regimens of ETN plus TWP and ETN plus MTX all can improve the clinical signs and symptoms and quality of life, There was no difference between these two groups in efficacy, and they were well tolerated in the treatment of elderly patients with active RA. Disclosure of Interest None Declared" @default.
- W2315492167 created "2016-06-24" @default.
- W2315492167 creator A5008917691 @default.
- W2315492167 creator A5023597320 @default.
- W2315492167 creator A5063898573 @default.
- W2315492167 creator A5066969372 @default.
- W2315492167 creator A5081920015 @default.
- W2315492167 date "2013-06-01" @default.
- W2315492167 modified "2023-09-26" @default.
- W2315492167 title "AB0295 Clinical study on etanercept combined with tripterygium wilfordii polyglycoside for treatment of eldly rheumatoid arthritis" @default.
- W2315492167 doi "https://doi.org/10.1136/annrheumdis-2013-eular.2617" @default.
- W2315492167 hasPublicationYear "2013" @default.
- W2315492167 type Work @default.
- W2315492167 sameAs 2315492167 @default.
- W2315492167 citedByCount "1" @default.
- W2315492167 countsByYear W23154921672020 @default.
- W2315492167 crossrefType "journal-article" @default.
- W2315492167 hasAuthorship W2315492167A5008917691 @default.
- W2315492167 hasAuthorship W2315492167A5023597320 @default.
- W2315492167 hasAuthorship W2315492167A5063898573 @default.
- W2315492167 hasAuthorship W2315492167A5066969372 @default.
- W2315492167 hasAuthorship W2315492167A5081920015 @default.
- W2315492167 hasConcept C126322002 @default.
- W2315492167 hasConcept C142724271 @default.
- W2315492167 hasConcept C197934379 @default.
- W2315492167 hasConcept C198451711 @default.
- W2315492167 hasConcept C204787440 @default.
- W2315492167 hasConcept C2777077863 @default.
- W2315492167 hasConcept C2777226972 @default.
- W2315492167 hasConcept C2777575956 @default.
- W2315492167 hasConcept C2780695664 @default.
- W2315492167 hasConcept C71924100 @default.
- W2315492167 hasConcept C90924648 @default.
- W2315492167 hasConceptScore W2315492167C126322002 @default.
- W2315492167 hasConceptScore W2315492167C142724271 @default.
- W2315492167 hasConceptScore W2315492167C197934379 @default.
- W2315492167 hasConceptScore W2315492167C198451711 @default.
- W2315492167 hasConceptScore W2315492167C204787440 @default.
- W2315492167 hasConceptScore W2315492167C2777077863 @default.
- W2315492167 hasConceptScore W2315492167C2777226972 @default.
- W2315492167 hasConceptScore W2315492167C2777575956 @default.
- W2315492167 hasConceptScore W2315492167C2780695664 @default.
- W2315492167 hasConceptScore W2315492167C71924100 @default.
- W2315492167 hasConceptScore W2315492167C90924648 @default.
- W2315492167 hasIssue "Suppl 3" @default.
- W2315492167 hasLocation W23154921671 @default.
- W2315492167 hasOpenAccess W2315492167 @default.
- W2315492167 hasPrimaryLocation W23154921671 @default.
- W2315492167 hasRelatedWork W1196035794 @default.
- W2315492167 hasRelatedWork W1586828706 @default.
- W2315492167 hasRelatedWork W1942301967 @default.
- W2315492167 hasRelatedWork W1988975600 @default.
- W2315492167 hasRelatedWork W2066441931 @default.
- W2315492167 hasRelatedWork W2112836912 @default.
- W2315492167 hasRelatedWork W2129948300 @default.
- W2315492167 hasRelatedWork W2312539884 @default.
- W2315492167 hasRelatedWork W2312765564 @default.
- W2315492167 hasRelatedWork W2322293030 @default.
- W2315492167 hasRelatedWork W2353466245 @default.
- W2315492167 hasRelatedWork W2358145120 @default.
- W2315492167 hasRelatedWork W2373186848 @default.
- W2315492167 hasRelatedWork W2375363171 @default.
- W2315492167 hasRelatedWork W2379436644 @default.
- W2315492167 hasRelatedWork W2380068251 @default.
- W2315492167 hasRelatedWork W2385166155 @default.
- W2315492167 hasRelatedWork W2416830647 @default.
- W2315492167 hasRelatedWork W765976976 @default.
- W2315492167 hasRelatedWork W88956580 @default.
- W2315492167 hasVolume "72" @default.
- W2315492167 isParatext "false" @default.
- W2315492167 isRetracted "false" @default.
- W2315492167 magId "2315492167" @default.
- W2315492167 workType "article" @default.